RSKD (RSKD) insider schedules 286,599-share sale and discloses 10b5-1 trades
Rhea-AI Filing Summary
RSKD reports that an affiliate has filed to potentially sell 286,599 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services on the NYSE, with an aggregate market value of $1,848,563.55 as of a planned sale date of August 14, 2026.
The shares consist of 250,000 founders shares acquired on November 26, 2012 and 36,599 restricted stock units dated October 1, 2025. The filing also lists recent sales under a Rule 10b5-1 trading plan by Assaf Feldman, including 450,000 shares sold on August 12, 2026 and additional sales in July 2026.
Positive
- None.
Negative
- None.
Key Figures
Shares proposed for sale: 286,599 shares of common stock
Aggregate market value of proposed sale: $1,848,563.55
Founders shares included: 250,000 shares
+4 more
7 metrics
Shares proposed for sale
286,599 shares of common stock
Planned sale through Morgan Stanley Smith Barney LLC on 08/14/2026
Aggregate market value of proposed sale
$1,848,563.55
Value of 286,599 common shares to be sold
Founders shares included
250,000 shares
Founders shares dated 11/26/2012 listed as securities to be sold
Restricted stock units included
36,599 units
Restricted Stock Units dated 10/01/2025 listed as securities to be sold
10b5-1 sale on 08/12/2026
450,000 shares for $2,703,465.00
Common stock sold under a Rule 10b5-1 plan by Assaf Feldman
10b5-1 sale on 07/06/2026
32,588 shares for $169,207.04
Common stock sold under a Rule 10b5-1 plan by Assaf Feldman
10b5-1 sale on 07/01/2026
230,512 shares for $1,156,801.28
Common stock sold under a Rule 10b5-1 plan by Assaf Feldman
Key Terms
Founders Shares, Restricted Stock Units, 10b5-1 Sales, Form 144
4 terms
Restricted Stock Units financial
"Common | 10/01/2025 | Restricted Stock Units | Issuer"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
10b5-1 Sales regulatory
"10b5-1 Sales for ASSAF FELDMAN 220 5th Avenue"
10b5-1 sales are pre-arranged stock-trading plans that let company insiders automatically buy or sell shares according to a fixed schedule or formula, even if they later learn confidential information. Think of it as setting up an automatic thermostat for trades: it creates a clear, documented path that can protect insiders from insider-trading accusations and gives investors a signal about predictable insider activity—though it can also simply be a way for insiders to diversify or raise cash.
Form 144 regulatory
"144: Securities To Be Sold Common | 11/26/2012"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
FAQ
What recent 10b5-1 plan sales by Assaf Feldman in RSKD stock are disclosed?
Assaf Feldman is shown to have sold 450,000 common shares for $2,703,465.00 on August 12, 2026, 32,588 shares for $169,207.04 on July 6, 2026, and 230,512 shares for $1,156,801.28 on July 1, 2026 under a Rule 10b5-1 plan.
Is the RSKD Form 144 linked to a Rule 10b5-1 trading plan?
The filing notes that sales during the past three months for Assaf Feldman were 10b5-1 Sales, including transactions on July 1, July 6, and August 12, 2026, indicating they were executed under a Rule 10b5-1 trading plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.